Abstract Library

#1407 Nutritional Status and Nutritional Risk in Patients with Neuroendocrine Tumors

Introduction: Malnutrition is common in patients with cancer and is associated with impaired function. No data are available on nutritional status (NS) and nutritional risk (NR) in patients with neuroendocrine tumors (NET).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Borre M

Authors: Borre M, Dam G, Knudsen A, Grønbæk H,

Keywords: NRS-2002, Nutrition impact symptoms,

#783 A Comparison of Three Chromogranin A Assays in Patients with Neuroendocrine Tumors

Introduction: Chromogranin A (CgA) is the most important general tumor marker used in the diagnosis and follow-up of patients with neuroendocrine tumors (NET). CgA assays may have different sensitivities, which is of importance for the clinical diagnosis and handling of NET patients.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Grønbæk H

Authors: Høj L, Parkner T, Knudsen C, Grønbæk H,

Keywords: neuroendocrine tumor, Chromogranin A,

#487 Validation of Chromogranin A Assays in Patients with Neuroendocrine Tumors

Introduction: CgA is the most important biochemical marker for evaluation of NETs. Different assays with different accuracy exist.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Høj L, Parkner T, Knudsen C, Grønbæk H,

Keywords: neuroendocrine, CgA, assay,